1. Executive read
The observable problem is not a missing feature. Rival B is reducing perceived adoption risk: a clearer onboarding promise, tighter packaging and public signals that it is moving upmarket. Reviews repeatedly mention onboarding time, while your public materials do not state a concrete time-to-value expectation.
Mid-market deals appear to be decided on time-to-value before feature depth becomes the deciding factor.
2. Evidence ledger
3. Recommended moves
01. Publish a concrete onboarding and time-to-value expectation before changing list price.
02. Rebuild the trial around a single 7-day proof of value.
03. Give sales a short implementation-risk rebuttal based on the same evidence ledger.
If win/loss evidence shows feature gaps are named more often than adoption risk, the recommendation should be downgraded and the roadmap hypothesis revisited.